Recent Analysts’ Ratings Changes for CVS Health (CVS)

Posted by on May 14th, 2026

A number of firms have modified their ratings and price targets on shares of CVS Health (NYSE: CVS) recently:

  • 5/12/2026 – CVS Health had its price target raised by JPMorgan Chase & Co. from $101.00 to $111.00. They now have an “overweight” rating on the stock.
  • 5/12/2026 – CVS Health had its price target raised by Sanford C. Bernstein from $94.00 to $106.00. They now have an “outperform” rating on the stock.
  • 5/11/2026 – CVS Health had its price target raised by TD Cowen from $105.00 to $110.00. They now have a “buy” rating on the stock.
  • 5/11/2026 – CVS Health had its price target raised by TD Cowen from $105.00 to $110.00. They now have a “buy” rating on the stock.
  • 5/9/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
  • 5/8/2026 – CVS Health had its “hold (c)” rating reaffirmed by Weiss Ratings.
  • 5/8/2026 – CVS Health had its price target raised by Wells Fargo & Company from $102.00 to $103.00. They now have an “overweight” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by Royal Bank Of Canada from $93.00 to $107.00. They now have an “outperform” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by Barclays PLC from $93.00 to $101.00. They now have an “overweight” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by UBS Group AG from $97.00 to $100.00. They now have a “buy” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by Truist Financial Corporation from $98.00 to $102.00. They now have a “buy” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by DA Davidson from $80.00 to $100.00. They now have a “buy” rating on the stock.
  • 5/7/2026 – CVS Health had its price target raised by Deutsche Bank Aktiengesellschaft from $88.00 to $92.00. They now have a “buy” rating on the stock.
  • 5/5/2026 – CVS Health had its price target raised by HSBC Holdings plc from $83.00 to $85.00. They now have a “hold” rating on the stock.
  • 4/15/2026 – CVS Health had its price target raised by Robert W. Baird from $92.00 to $94.00. They now have an “outperform” rating on the stock.
  • 3/31/2026 – CVS Health had its price target lowered by Piper Sandler from $101.00 to $99.00. They now have an “overweight” rating on the stock.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. CVS Health’s payout ratio is currently 117.18%.

Insider Buying and Selling at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares in the company, valued at $907,714.14. The trade was a 87.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.85% of the stock is owned by corporate insiders.

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Featured Stories

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.